StocksMedium•12 November 2026•
1 min read
Zealand Pharma Expects $400M Cash Inflow from Roche in Q4
Key Facts
1Zealand Pharma expects a net $400 million milestone payment from Roche in the fourth quarter of 2026.
2The company narrowed its 2026 operating expense guidance to between DKK 2.7 billion and DKK 3.0 billion.
Zealand Pharma expects a net $400 million milestone payment from Roche in the fourth quarter of 2026. Seeking Alpha reported that the cash inflow is tied to milestone achievements within the collaboration between the two companies.
The company narrowed its 2026 operating expense guidance to between DKK 2.7 billion and DKK 3.0 billion. ZLDPF closed at $36.75 on November 10, 2026, while RHHBY closed at $60.57 on November 11, 2026.